NCT06254859

Brief Summary

This study examines the impact of intraoperative recurrent laryngeal nerve monitoring signal changes on the postoperative voice quality of thyroid surgery patients. By analyzing extensive surgical data and postoperative voice recordings, the investigation seeks to identify patterns in the variations of these signals and their correlation with voice quality outcomes. The goal is to enhance clinical understanding and surgical practices, allowing for more precise assessments of nerve function, informed surgical interventions, and improved postoperative patient well-being.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 12, 2024

Completed
18 days until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 20, 2025

Status Verified

May 1, 2025

Enrollment Period

1.8 years

First QC Date

January 30, 2024

Last Update Submit

May 17, 2025

Conditions

Keywords

acoustic analysisthyroid cancer

Outcome Measures

Primary Outcomes (5)

  • Intraoperative electromyographic signals.

    Recording intraoperative electromyographic signals, including vagus nerve V1 and V2 signals, recurrent laryngeal nerve R1 and R2 signals.

    During the surgery, record R1 and V1 signals when initially identifying the recurrent laryngeal nerve or vagus nerve. After the surgery, record R2 and V2 signals upon re-identification of the recurrent laryngeal nerve or vagus nerve.

  • Voice analysis data(SPL)

    Recording data(SPL) of voice tests before and after the surgery, sound pressure level in dB(A)

    Before the surgery, 2 weeks after the surgery, 2 months after the surgery, 4 months after the surgery, and 6 months after the surgery.

  • Voice analysis data(F0)

    Recording data(F0) of voice tests before and after the surgery, F0 in Hz

    Before the surgery, 2 weeks after the surgery, 2 months after the surgery, 4 months after the surgery, and 6 months after the surgery.

  • Voice analysis data(Jitter)

    Recording data(Jitter) of voice tests before and after the surgery, Jitter in percentage

    Before the surgery, 2 weeks after the surgery, 2 months after the surgery, 4 months after the surgery, and 6 months after the surgery.

  • Voice analysis data(Shimmer)

    Recording data(Shimmer) of voice tests before and after the surgery, Shimmer in percentage

    Before the surgery, 2 weeks after the surgery, 2 months after the surgery, 4 months after the surgery, and 6 months after the surgery.

Secondary Outcomes (5)

  • RBH

    Before the surgery, 2 weeks after the surgery, 2 months after the surgery, 4 months after the surgery, and 6 months after the surgery.

  • VHI-30

    Before the surgery, 2 weeks after the surgery, 2 months after the surgery, 4 months after the surgery, and 6 months after the surgery.

  • Neural Width

    During surgery.

  • Is there branching

    During surgery.

  • Number of neural branches

    During surgery.

Study Arms (4)

Normal Signal Group.

During the surgical procedure, there was no occurrence of a decrease in recurrent laryngeal nerve signals or a decrease of less than 10%.

Procedure: Traditional thyroid surgery.

Signal Decrease 10-50%.

During the surgical procedure, the signal of the recurrent laryngeal nerve decreased by 10-50%.

Procedure: Traditional thyroid surgery.

Signal Decrease 50-90%.

During the surgical procedure, the signal of the recurrent laryngeal nerve decreased by 50-90%.

Procedure: Traditional thyroid surgery.

Signal Absence Group.

During the surgical procedure, the signal of the recurrent laryngeal nerve decreased by more than 90% or completely disappeared.

Procedure: Traditional thyroid surgery.

Interventions

The patient undergoes traditional thyroid surgery with concurrent intraoperative nerve monitoring technology.

Normal Signal Group.Signal Absence Group.Signal Decrease 10-50%.Signal Decrease 50-90%.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

People with thyroid cancer who are planned to undergo traditional surgical treatment.

You may qualify if:

  • Age 20-60 years old.
  • Planned conventional unilateral thyroid lobectomy + isthmus resection + central compartment lymph node dissection.

You may not qualify if:

  • History of past head and neck surgeries.
  • Pronunciation system defect and disorder history.
  • History of vocal cord polyps or nodules.
  • History of upper respiratory tract infection in the 2 weeks before surgery or postoperative infection history.
  • History of neurological disorders.
  • Abnormalities in the throat.
  • Preoperative damage to throat morphology or motor function.
  • Preoperative functional voice or language disorders, noticeable hoarseness, or difficulty in pronunciation.
  • Pre- and postoperative laryngoscopic examination showing vocal cord paralysis and arytenoid joint dislocation.
  • Neurological disorders causing abnormal throat function.
  • Patient unable to cooperate with VHI (Voice Handicap Index) assessment and voice spectrum examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fujian Medical University Union Hospital

Fuzhou, Fujian, 350001, China

RECRUITING

MeSH Terms

Conditions

Thyroid NeoplasmsThyroid Cancer, Papillary

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid DiseasesAdenocarcinoma, PapillaryAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type

Central Study Contacts

Bo Wang Professor, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Head of Thyroid Surgery, Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

January 30, 2024

First Posted

February 12, 2024

Study Start

March 1, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

May 20, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations